Section 3: Production and Compounding

3PC-037

STERILITY OF SINGLE USE VIALS WHEN ACCESSED USING A CLOSED SYSTEM TRANSFER DEVICE (submitted in 2019)

3PC-036

CASE STUDY: DEVELOPMENT OF AN OINTMENT ACCORDING TO THE PHARMACEUTICAL INSPECTION CONVENTION GUIDELINE (submitted in 2019)

3PC-035

93% OXYGEN SELF-PRODUCTION: EXPERIENCE IN NA ITALIAN HOSPITAL (submitted in 2019)

3PC-034

CONTENT UNIFORMITY OF EXTEMPORANEOUS COMPOUNDED SUSPENSIONS (submitted in 2019)

3PC-033

INTRACAMERAL AND INTRASTROMAL VORICONAZOLE ADMINISTRATION IN FUSARIUM KERATITIS (submitted in 2019)

3PC-032

AUTOLOGOUS TISSUE ADHESIVE IN OPHTHALMOLOGICAL SURGERY (submitted in 2019)

3PC-031

CURRENT STATE OF THE ANTI-INFECTIVE OPHTHALMIC COMPOUNDING FORMULATION IN PHARMACY SERVICES: A NATIONAL SURVEY (submitted in 2019)

3PC-030

ANALYTICAL METHOD VALIDATION TO CARRY OUT PHYSICOCHEMICAL STABILITY STUDIES OF METHADONE ORAL SOLUTIONS. (submitted in 2019)

3PC-029

PAEDIATRIC DRUG RESISTANT EPILEPSY: NITRAZEPAM 1MG/ML SOLUTIONS TO AVOID CLINICAL THERAPEUTIC ERROR (submitted in 2019)

3PC-028

COMPOUNDING AN ORAL LIQUID FORMULATION OF DIAZEPAM ALCOHOL FREE (submitted in 2019)

3PC-027

LONG TERM STABILITY OF A READY TO USE TOPICAL ANAESTHETIC GEL KIT (submitted in 2019)

3PC-026

FORMULATION AND GALENIC CHARACTERISATION OF A TACROLIMUS ADHESIVE GEL FOR TREATMENT OF ULCERATIVE PROCTITIS (submitted in 2019)

3PC-025

MAGISTRAL FORMULATION FOR A PATIENT WITH MULTIPLE FOOD ALLERGY (submitted in 2019)

3PC-024

THE EFFECTS OF FREEZE-THAW CYCLING ON THE STABILITY OF THE ADALIMUMAB BIOSIMILAR SB5 (submitted in 2019)

3PC-023

DEVELOPMENT AND VALIDATION OF A DISCRIMINATIVE METHOD FOR ANTHRACYCLINES DRUGS USED IN ONCOLOGY BY VISIBLE SPECTROMETER (submitted in 2019)

Pages